Combination Therapy
Showing 51 - 75 of >10,000
Small Cell Lung Cancer Trial in Seoul (Durvalumab)
Active, not recruiting
- Small Cell Lung Cancer
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Nov 6, 2022
Liver and Biliary Cancer Patients Treated With PD-1 Combination
Active, not recruiting
- Hepatocellular Carcinoma
- Bile Duct Cancer
- [68Ga]FAPI PET/CT and [18F]FDG PET/CT
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Dec 14, 2022
Hypertension, Arterial Hypertension Trial in Changsha (Quadruple combination of half doses therapy?Dual combination of standard
Recruiting
- Hypertension
- Arterial Hypertension
- Quadruple combination of half doses therapy→Dual combination of standard dose therapy
- Dual combination of standard dose therapy→ Quadruple combination of half doses therapy
-
Changsha, Hunan, ChinaThe Third Xiangya Hospital of Central South University
Jul 13, 2022
Schizophrenia Trial in Shanghai (sodium valproate with Clozapine, modified electroconvulsive therapy(MECT) with Clozapine,
Completed
- Schizophrenia
- sodium valproate with Clozapine
- +3 more
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 1, 2022
HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection Trial in Marseille (CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN
Terminated
- HBe Negative Chronic Hepatitis B
- Hepatitis B Viral Infection
- CLEVUDINE + TENOFOVIR PLACEBO
- +2 more
-
Marseille, FranceHôpital Saint Joseph
Jan 30, 2023
Diabetic Foot Ulcers, Diabetic Wound Trial in Mashhad (Methylene Blue, Milk (control), Methylene Blue and Platelet-Rich
Recruiting
- Diabetic Foot Ulcers
- Diabetic Wound
- Methylene Blue
- +3 more
-
Mashhad, Razavi Khorasan, Iran, Islamic Republic ofMashhad University of Medical Sciences
May 10, 2023
Cocaine Dependence Trial in Houston (Doxazosin, Modafinil, cocaine)
Completed
- Cocaine Dependence
- Doxazosin
- +3 more
-
Houston, TexasMichael Debakey VA Medical Center
Apr 19, 2022
Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)
Not yet recruiting
- Primary Hepatocellular Carcinoma
- Portal Vein Thrombosis
- Recombinant human adenovirus type 5 + TACE
- (no location specified)
May 14, 2023
Benign Prostatic Hyperplasia, Overactive Bladder Trial in Mansoura (Tadalafil 5mg, Tamsulosin Hcl 0.4 mg, solifenacin 10 mg)
Active, not recruiting
- Benign Prostatic Hyperplasia
- Overactive Bladder
- Tadalafil 5mg
- +2 more
-
Mansoura, EgyptUrology and Nephrology center
Aug 9, 2022
Locally Advanced or Metastatic Solid Tumors Trial in China (IN10018+PLD, IN10018+PLD+Toripalimab)
Active, not recruiting
- Locally Advanced or Metastatic Solid Tumors
-
Anyang, Henan, China
- +6 more
Apr 25, 2023
Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)
Active, not recruiting
- Gastrointestinal Cancer
- Cobimetinib
- +2 more
-
New York, New York
- +1 more
Nov 29, 2022
Traumatic Brain Injury Trial in Cincinnati (Full-band Electrocorticography, Treatment Algorithm)
Not yet recruiting
- Traumatic Brain Injury
- Full-band Electrocorticography
- Treatment Algorithm
-
Cincinnati, OhioUniversity of Cincinnati
Jul 7, 2022
Sarpogrelate, Blood Viscosity, Peripheral Arterial Disease Trial in Uijeongbu (Sarpogrelate Sustained Release/Aspirin, Aspirin)
Recruiting
- Sarpogrelate
- +3 more
- Sarpogrelate Sustained Release/Aspirin
- Aspirin
-
Uijeongbu, Gyeonggi-do, Korea, Republic ofThe Catholic University of Korea Uijeongbu St. Mary's Hospital
Feb 6, 2023
Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)
Recruiting
- Metastatic Pancreatic Cancer
- MesoPher
- Mitazalimab
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Dec 6, 2022
Real-world, 52-week Prospective Study to Capture Reasons for
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive (COPD)
- Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
- (no location specified)
Jun 13, 2023
Schizophrenia Trial in Baltimore (Anti-inflammatory Combination Therapy, Placebo)
Completed
- Schizophrenia
- Anti-inflammatory Combination Therapy
- Placebo
-
Baltimore, MarylandMaryland Psychiatric Research Center
Mar 1, 2022
Biliary Tract Cancer Trial in Kaohsiung, Taichung (D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX)
Recruiting
- Biliary Tract Cancer
- D07001-softgel capsules + Xeloda (or TS-1)
- mFOLFOX
-
Kaohsiung, Taiwan
- +4 more
Dec 22, 2022
Acute Myeloid Leukemia, MDS Trial in China (TQB2928 Injection + Azacitidine for injection)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- TQB2928 Injection + Azacitidine for injection
-
Beijing, Beijing, China
- +8 more
Aug 22, 2023
Femoropopliteal Artery Disease Trial in Seoul (Combination therapy of atherectomy and DCB, DCB alone)
Not yet recruiting
- Femoropopliteal Artery Disease
- Combination therapy of atherectomy and DCB
- DCB alone
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 23, 2022
Post Traumatic Stress Disorder Trial in San Diego (Brexpiprazole, Sertraline, Placebo)
Recruiting
- Post Traumatic Stress Disorder
- Brexpiprazole
- +2 more
-
San Diego, CaliforniaFor additional information regarding sites, contact 844-687-8522
Jul 14, 2022
Advanced Rectal Cancer, Liver Metastasis, Pulmonary Metastasis Trial in Shanghai (a combination therapy)
Not yet recruiting
- Advanced Rectal Cancer
- +3 more
- a combination therapy including tislelizumab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 9, 2022
Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3 Trial in Washington, Hackensack (NY-ESO-1 Peptide
Not yet recruiting
- Ovarian Cancer Stage IV
- +2 more
- NY-ESO-1 Peptide vaccine
- Nivolumab
-
Washington, District of Columbia
- +2 more
Jul 28, 2022
Depression Trial in Rawalpindi (L-methylfolate, Vitamin B12, magnesium)
Active, not recruiting
- Depression
- L-methylfolate
- +2 more
-
Rawalpindi, Punjab, PakistanPakistan Railway Hospital, IIMC-T, Riphah International Universi
Jun 26, 2023
Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)
Recruiting
- Solid Tumor
- Hematological Malignancy
-
East Melbourne, Victoria, Australia
- +4 more
Jan 11, 2023